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function in ankylosing spondylitis: A cohort study
Sinead Brophy, PhD, FRCPH, Roxanne Cooksey, MSc, Helen Davies, PhD,
Michael S. Dennis, MBBCh, MD, FRCPsych, Shang-Ming Zhou, PhD,
and Stefan Siebert, MBBCh, MRCP, PhDObjectives: Exercise is reported to improve function for people with ankylosing spondylitis (AS)
but it is not clear if this effect is causal or if patients with milder disease find it easier to exercise.
This study examines the effect of exercise and motivation to exercise on function, while controlling
for disease severity.
Methods: Participants who were members of an existing AS cohort were asked about physical
activity, motivation to exercise, function, and disease severity. Path analysis on STATA was used to
examine the correlation between factors associated with function at time of exercise and with
function after 3 months of follow-up.
Results: The response rate to the questionnaire was 88% (326/371). Improvement in function was
greatest for people with higher physical activity levels and those who were more motivated to
exercise—this was especially the case for patients with the most severe disease activity. The effect of
motivation to exercise not only had a direct effect on function, but also an indirect effect of
improving activity levels thereby improving both current and future function. People with high
intrinsic motivation (driven by pleasure) had the greatest benefit to activity and function.
Conclusions: Exercise does improve function, especially for those with severe disease. In addition,
motivation alone improves function as much as exercising itself. Therefore, interventions targeting
motivation to exercise would have as much effect on improving function as interventions offering
exercise opportunities. In addition, any intervention that both improves motivation and increases
opportunities to exercise would have a 2-fold influence on function.
& 2013 Elsevier Inc. All rights reserved. Semin Arthritis Rheum 42:619–626
Keywords: Ankylosing spondylitis, Function, Motivation, ActivityAnkylosing spondylitis (AS) is the second mostcommon inflammatory rheumatic disease and it ischaracterized by inflammatory back pain and
sacroiliitis. It is associated with peripheral arthritis, enthe-
sitis, uveitis, inflammatory bowel disease, and psoriasis [1].
Previous work has documented the beneficial effects of
exercise on various aspects of health for AS patients,
including physical function, disease activity, spinal mobi-
lity, chest expansion, global well-being, quality of life, and
fatigue [2–5]. Research has suggested that AS is associated$ - see front matter & 2013 Elsevier Inc. All rights reserved.
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which would provide an additional indication for AS
patients to develop and maintain cardiovascular fitness.
Current recommendations for the management of AS
include appropriate medication and exercise for all AS
patients as core recommendations [8]. In fact, recent
recommendations suggest that physiotherapy should be
started as soon as AS is diagnosed, at all disease stages and
using group physiotherapy and spa exercises [9]. Benefits
of home and group-based exercise have been observed
[10,11], a the majority of the people with AS do not
exercise frequently, with just 18% [12], 23% [13,14],
and 34.4% [15] of the patients regularly exercising in
different studies. The main barriers were due to fatigue’
with 71% reporting that “exercise tires me” or “I am
fatigued by exercise” [14,15]. It can be argued that619
620 Exercise & Motivation in ASexercise is undertaken by the less severe patients and is
really only feasible for those with low pain and fatigue
levels. This means exercise may appear to improve the
outcome of the AS but that this is actually reverse
causation, in that those with severe pain, fatigue, and
disease activity cannot exercise, while those with milder
disease can and do exercise.
Here, we set out to investigate this by controlling for
disease severity and examining the effect of exercise on
function in AS.
METHODS
Study design
Cohort study.
Participants
As part of the Medical Research Council/NISCHR
Patient Research Cohort Initiative, people with AS were
recruited and asked to complete questionnaires about
multiple aspects of their disease every 3–6 months. The
protocol for this study has previously been published [16]
and involves 572 patients recruited through their rheu-
matologist or general practitioner between 2009 and
2011. These questionnaires captured AS-specific disease
activity and function and quality of life.
A separate exercise questionnaire was circulated 1 year
into the cohort study. This was sent to a total of
371 people, as 201 patients had an incomplete set of
questionnaires concerning other aspects of their disease
(primarily due to being recently recruited), had dropped
out of the cohort, moved, or died. The exercise ques-
tionnaire included instruments related to physical activity
and motivation to exercise.
Three months after completion of the exercise
questionnaire’ patients were surveyed again in relation
to disease activity and function.
Rating instruments
Behavioral Regulation in Exercise Questionnaire
Participants were requested to complete the validated
modified Behavioral Regulation in Exercise Question-
naire (BREQ-2) [17] which explores motivation to
exercise. The BREQ-2 consists of 19 items which
measure the stages of self-determination on a continuum
from amotivation (lack of motivation), external regula-
tion (exercising to obtain an external reward), intro-
jected regulation (exercising in order to avoid negative
feelings, for example guilt, associated with not exercising),
identified regulation (recognizing the benefits of exercise
for oneself)’ and intrinsic regulation (choosing freely to
exercise). The unidimensional relative autonomy index
(RAI) [18], derived from the subscales of BREQ-2, is
used here and gives an indication of the degree of self-
determination to exercise.International Physical Activity Questionnaire—short
form
Physical activity was assessed using the International
Physical Activity Questionnaire-ShortForm (IPAQ-SF)
[19], a validated instrument comprising of four items that
estimates the levels of vigorous activity, moderate activity,
walking and time spent sitting during the previous 7 days.
The volume of an activity is computed by weighting each
type of activity by its energy requirements defined in
metabolic equivalent tasks (METs) [19] and multiplying
the MET score by the time (in minutes) the activity was
performed for. Scores are presented as MET-minutes per
week. The IPAQ-SF classifies populations into low
(scores of o599), moderate (scores between 600 and
2999)’ or high physical activity level (scores over 3000)
groups.
EQ5D
The EQ5D is a health status/quality of life questionnaire
which comprises of five dimensions: mobility, self-care,
usual activities, pain/discomfort’ and anxiety/depression.
Each dimension has three levels: no problems, some
problems, severe problems. The dimensions are scored as
1, 2, or 3. A score of 11111 indicates no problem on
any of the five dimensions, a score of 11223 would
indicate no problem with mobility and self-care but some
problems with usual activities and moderate pain/dis-
comfort and extreme anxiety and depression. The score is
then translated using a country appropriate single sum-
mary score. A score of 1 indicates no impairment, a score
below 1 indicates lower quality of life/health status, 0
indicates death and negative scores indicate a health state/
quality of life worse than death. These scores can be used
to calculate quality adjusted life years (QALY).
Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale [20,21] has
14 questions relevant to anxiety (7 statements) and
depression (7 statements). Each question has four possible
responses which are scored on a scale of 0–3, the
maximum score is 21 for depression and 21 for anxiety
with values of 11 or more on the relevant subscale
indicating probable depression. Depression has been
found to be associated with functional limitations in
RA [22,23] and AS [24] and psychological factors such as
helplessness and depression serve as mediators in the link
between disease activity and functional limitations [24].
Bath AS-indices
Other measures collected during the study were Bath
Ankylosing Spondylitis Disease Activity Index (BASDAI)
[25] and the Bath Ankylosing Spondylitis Functional
Index (BASFI) [26]. BASDAI is a self-reported, 6-item
questionnaire measuring disease activity on a 10-cm
visual analog scale, from none (0 mm) to very severe
S. Brophy et al. 621(100 mm). Items included are severity of fatigue, spinal and
peripheral joint pain, localized tenderness’ and morn-
ing stiffness over the past week. The lower the score the
lower the disease activity. The minimum clinically
important difference (MCID), which is the minimum
level of change of an outcome measure that is con-
sidered to be clinically relevant, for BASDAI was 10 mm
(scale 0–100) [27]. BASFI is a self-reported, 10-item
questionnaire’ evaluating the ability to function and cope
with activities of daily living over the past week using a
10-cm VAS scale, from no limitations (0 mm) to very
severe functional limitation (100 mm). The lower the
score the better the function. The higher the score the
more impaired the function. The MCID for BASFI was
7 mm [27].Ethical approval
The study was given favorable ethical approval by the
London Multi-centre Research Ethics committee [16].Statistical analysis
Descriptive statistics were produced for all variables and
exploratory analyses examined correlations of factors
related to variation in both current function and in future
function. The proportions of participants who reported
different types of motivation regulation were reported
using descriptive statistics and terciles were used to divide
the BASDAI into low, moderate, and high groups. Based
on the results from the exploratory analysis’ a path ana-
lysis using the sem command in STATA 12, was performed.
All meaningful relationships were first considered and
those that were non-significant (P4 0.05) were elimi-
nated from the final model. Path analysis allows two
regression models to be run together therefore’ taking
into account correlations on the path to the dependent
variable (functional score). The r2 value was used to assess
the proportion of the variation in function which can beTable 1 Demographic Table by Functional Level
Good Function (scoreo50), n ¼ 194
Male gender (n) 81.5% (155)
Age, mean (SD) 51.7 (14.5)
Anti TNF use (n) 13.9% (27)
Non-steroidal use (n) 86% (167)
EQ5D, mean (SD) 0.75 (0.2)
HAD score, mean (SD) 12.9 (5.3)
Disease severity
(scale 0–100)
27.7 (18.6)
Exercise
Low 12.9% (25)
Medium 43% (84)
High 43.8% (85)accounted for by the model. The likelihood ratio test was
used to test model fit.
RESULTS
The exercise questionnaire was completed by 326 out of
371 participants (88% response rate). The sample was
79% male, mean age 55 (SD  14), with a mean disease
duration of 22 years (SD  15) from the date of
diagnosis and 30 years (SD  15) from the date of first
symptoms. The average BASDAI and BASFI scores were
41 (SD  24) and 47 (SD  29), respectively on a scale
of 0–100. Those patients with poor function were older
and had higher anxiety and depression scores and lower
quality of life scores but there was no difference in gender
or medication prescription (Table 1).
Patients with high levels of disease activity (high
pain, fatigue, stiffness, BASDAI460 (scale 0–100)),
had a lower average physical activity score compared
to those with moderate and mild disease activity
(high disease severity—2017 MET-min/wk, moderate
disease severity—3347 MET-min/wk and mild disease
severity—3255 MET-min/wk respectively, P ¼ 0.0028).
The cut-offs for low activity are o600, moderate activity
600–2999, high activity43000 MET-min/wk. Thus,
those with moderate and low disease activity do report
high levels of physical activity per week.
Effect of physical activity on function (BASFI)
when controlling for disease severity (BASDAI)
BASFI is a measure of functional impairment and so a
lower BASFI score will indicate better functional ability
and less disability. Higher physical activity is associated
with better function in patients with moderate and severe
disease activity (Table 2). From Table 2 it can be seen that
each unit increase in physical activity category is asso-
ciated with an improved function score. However,
patients with more severe disease activity show more
change (improved function) with each increase inPoor Function (score450), n¼ 167 Difference (95% CI)
76.5% (127) –
58.4 (11.7) 6.7 (3.9–9.4)
18.6% (31) –
79% (132) –
0.41 (0.3) 0.33 (0.28–0.38)
15.5 (5.9) 2.6 (1.47–3.8)
56.8 (18.5) 29 (25.2–32.9)
49.7% (83) 36% (27–45%)
29.3% (49) 14% (4–23.5%)
21% (35) 23% (13–31.8%)
Table 2 Improvement in Function (BASFI) with Physical
Activity Level When Stratified by Disease Severity and
Controlled For Age
Impairment in Function Score
Slope/Coefficient (95% CI)
Low disease activity BASDAIo35 (scale 0–100)
Physical activity
Low 1
Medium 8.9 (17.9 to 0.02)
High 14.0 (23.3 to4.8)n
Age 0.39 (0.16–0.6)n
Moderate disease activity BASDAI 35–59
(scale 0–100)
Physical activity
Low 1
Medium 15.4 (24.4 to6.5)n
High 21.3 (30.2 to 12.5)n
Age 0.63 (0.37–0.89)n
High disease activity BASDAI460 (scale 0–100)
Physical activity
Low 1
Medium 8.0 (16.0 to0.08)n
High 19.9 (27.9 to11.8)n
Age 0.46 (0.22–0.7)n
nSignificant (Po0.05), a negative coefficient indicates improve-
ment in function. A positive coefficient indicates poorer function.
Table 3 The Effect of Motivation to Exercise on the
Functional Ability (BASFI) of AS Patients
Impairment in Function Score
Slope/Coefficient (95% CI)
Low disease activity BASDAIo35 (scale 0–100)
Motivation
None 1
Moderate 4.8 (5.2 to 15.0)
Motivated 5.9 (15.0 to 3.2)
High 11.22 (19.7 to2.7)n
Age 0.48 (0.25–0.7)n
Moderate disease activity BASDAI 35–59
(scale 0–100)
Motivation
None 1
Moderate 6.9 (18.6 to 4.6)
Motivated 13.6 (25.3 to1.9)n
High 16.9 (28.4 to5.3)n
Age 0.63 (0.35–0.91)n
High disease activity BASDAI460 (scale 0–100)
Motivation
None 1
Moderate 17.5 (26.4 to8.5)n
Motivated 21.5 (33.1 to9.8)n
High 24.2 (37.4 to11.1)n
Age 0.65 (0.33–0.97)n
nSignificant (Po0.05), a negative coefficient indicates improve-
ment in function. A positive coefficient indicates poorer function.
622 Exercise & Motivation in ASphysical activity category. For example, a medium level of
activity for those with moderate disease activity (BASDAI
35–59) is associated with an improved function (com-
pared to those in the low activity category) of 15.4 on a 1–
100 BASFI scale (1.5 cm on the 1–10 cm VAS scale)
which is both a statistically significant change and twice
the clinically relevant change [27]. However, for those
with milder disease (BASDAI less than 35) a high level of
activity is needed to see a comparable improvement in
function. In this analysis, a high BASDAI indicates high
disease activity (increased pain, fatigue) and a high BASFI
indicates impaired function. Therefore, a negative coeffi-
cient indicates an improvement in function.-0.15
(95%CI: -0.23 to -0.09) 
Physical Activity 
Function
BASDAI
(disease activity) Motivation
Age
0.26
(95%CI: 0.20 to 0.33)
e1 = 0.9 
(95%CI: 0.83 to 0.96) 
e2 = 0.37
(95%CI: 0.32 to 0.43)
-0.13
(95%CI: -0.2 to -0.06) 0.66
(95%CI: 0.61 to 0.71)
0.32
(95%CI: 0.23 to 0.42)
Figure 1 Model of factors associated with current function for
individuals with AS (using standardized regression coefficients
(b)).Effect of motivation to exercise on function
(BASFI) when controlling for disease severity
(BASDAI)
Increasing motivation to exercise is associated with better
function for patients with severe disease activity (Table 3).
At lower levels of disease activity (milder disease, BAS-
DAIo35) patients need to be highly motivated in
order to see significant improvements in function. The
effect of depression and anxiety was examined using the
HADS [21] score but this did not have a significant
effect on function (P ¼ 0.97) when adjusted for disease
severity.Path analysis examining effect of motivation
and physical activity on function
Current function
We used path analysis to fit two regression models
together and examine the effect of motivation and
exercise on function (see Fig. 1). We examined the effect
of physical activity on current function (see Fig. 1) and
found that higher disease activity (pain/fatigue) and aging
are the main factors which are associated with loss of
-0.13
(95%CI: -0.24 to -0.03) 
Previous
Physical Activity 
Current Function 
Current
BASDAIPrevious
Motivation
Age
0.72
(95%CI: 0.66 to 0.78) 0.17(95%CI: 0.08 to 0.26)
0.41 (95%CI: 0.28 to 0.53)
-0.13
(95%CI: -0.23 to -0.03)
e1 = 0.83 
(95%CI: 0.73 to 0.94)
e2 = 0.32 (95%CI:
0.25 to 0.40)
Figure 2 Model of effect of previous motivation and physical activity on function for individuals with AS (using standardized
regression coefficients (b)).
S. Brophy et al. 623function. However, both motivation and physical activity
have an effect in increasing function. If motivation
increases this has a positive effect on function both
directly and indirectly by influencing physical activity
levels. Therefore, changing motivation to exercise will
have a greater effect than just improving a patient’s
exercise levels in isolation. A single standard deviation
change in motivation is directly associated with an
increased function of 0.14 of a standard deviation and
indirectly improves function by increasing activity by
0.34 of a standard deviation which will in turn, improve
function. The r2 of this model was 0.63 indicating a
significant proportion of the variation in function can be
accounted for by the variables in this model. The
likelihood ratio test showed good model fit (P ¼ 0.7 or
no significant difference between model predicted/
expected and observed data). The BASDAI (disease
activity) did not significantly affect level of physical
activity when adjusted for motivation.Future function
We examined the effect of physical activity on future
function. The current activity was measured in the
exercise questionnaire and function was assessed 3
months later (Fig. 2). Motivation and physical activity
influences future function in that higher levels of previous
activity and higher motivation to exercise in the past
lead to lower functional impairment. For example, a 1
standard deviation change in previous motivation leads to
a 0.13 standard deviation improvement in current
function and a 0.41 standard deviation increase in
physical activity levels. A 1 standard deviation change in
past physical activity leads to a 0.13 standard deviation
improvement in current function. The r2 of this model
was 0.68 indicating a significant proportion of the
variation in function can be accounted for using age,
current disease activity, previous motivation level’ and
previous physical activity level. The likelihood ratio testshowed a good fit of the model (P ¼ 0.1, showing no
significant difference in observed [data] and expected
[model predicted]). The BASDAI (disease activity) did
not significantly affect level of physical activity when
adjusted for motivation.
Table 4 shows the analysis of the important factors
in regulating motivation in patients and their influence
on exercise and function. This highlights that intrinsic
motivation (freely choosing to exercise because it is
pleasurable and fun) is associated with the greatest effect
on exercise level and benefit in function. Identified
regulation (perceiving exercise as fundamentally impor-
tant and beneficial) was also important, as was introjected
regulation (exercising to avoid feeling guilty or ashamed)
to a minor degree. External motivation (to please others)
was of no benefit.
DISCUSSION
This study was conducted to explore the effect of exercise
and motivation to exercise on the functional ability of
people with AS, while controlling for severity, a potential
confounding factor of function, exercise, and motivation.
We found that exercise does improve function when
controlling for disease activity (pain/fatigue). It is at the
higher levels of disease activity (pain/fatigue) that smaller
changes in activity will have most improvement in
function. In addition, motivation to exercise improves
function both indirectly, by increasing exercise levels, and
directly. Therefore, interventions aimed at enhancing
motivation to exercise comined with provision of access
to exercise would improve function 2-fold, compared to
providing access to exercise programmes and facilities alone.
Our findings are in line with findings from studies in
other forms of arthritis. For example, studies with
rheumatoid arthritis (RA) patients have found that lack
of motivation and lack of beliefs related to the benefits of
exercise are factors strongly associated with inactivity
[28,29] and motivation significantly determines physical
Table 4 Mode of Motivation Regulation and Exercise and Function Regulation
Amotivation External Introjected Identified Intrinsic
Description “I can’t see why I should
bother to exercise”
“To please
other
people”
I feel guilty when I
don’t exercise”
“Because I value the
benefits of
exercise”
“Because I think
exercise is
fun”
Exercise b
slope
667
(1242 to92)n
86.33
(433 to
606)
274 (91 to 638) 994 (651.5–1336)n 1320 (960–
1680)n
Function b
slope
6.6 (2.2–11.1)n 0.1 (4.1
to 3.9)
3.9 (6.7
to1.1)n
7.3 (10.1
to4.7)n
11.7 (14.3
to8.9)n
nSignificant (Po0.05).
624 Exercise & Motivation in ASactivity levels, with a more autonomous motivation style
predicting higher levels of physical activity [29,30]. Thus,
improving self-efficacy is as important in improving
physical activity. Intrinsic and identified motivation
appear particularly important, so exercise referral or
advising physiotherapy are unlikely to result in improved
exercise or function. Instead strategies should include
working with people to improve intrinsic motivation such
as motivational interviewing and goal setting.
People with RA and knee osteoarthritis in the lowest
quartile in terms of function, when given physical activity
coaching, had the largest mean physical improvement
over baseline [31]. Therefore, it is the older, more disabled
patients who should be targeted with improving activity as
these are the patients who benefit most.
We found people with higher disease activity under-
took less physical activity compared to those with
moderate to mild disease activity. This finding is similar
to that in RA in that the younger, higher educated, lower
disease activity, autonomous regulated patients that had
higher activity levels [30]. However, our study differs
from other studies which have found that people with
more pain (and osteoarthritis) were more motivated
(though not necessarily more active) [32] and in AS, it
has previously been found that people with more
disability were found to exercise more frequently than
those with less disability [12].Limitations of the study and future work
The physical activity measure in this study is self-reported
and therefore the levels of physical activity may not always
be accurate. Often people over estimate their activity and
future studies should use a combination of methods such as
a questionnaire combined with pedometer or accelerometer
in order to get accurate estimates of activity [33].
In addition, the sample consists of patients who are
enthusiastic to complete questionnaires about their AS
and may represent an inherently motivated group that is
not representative of the general AS population.
Finally, in patients with AS, disease activity correlates
weakly with acute phase responses; however, acute phaseresponse may have an effect on fatigue and relatively
motivation to exercise. We used the BASDAI which does
not include acute phase reactants, but the Ankylosing
Spondylitis Disease Activity Score [34] does include acute
phase response and it is possible that a study using
ASDAS may present slightly different results.
Future work needs to examine how to enhance
motivation as wells as provide activity facilities and
programmes. Enhancement of motivation can be
achieved by a variety of approaches, ranging in complex-
ity and style from the basic educational, to behavioral
activity diaries and goal setting (including motiva-
tional interviewing), through to more comprehensive
cognitive behavioral therapy and mindfulness-based
interventions. For example, a unique and tailored health-
promotion intervention aimed at increasing physical
activity levels in individuals with arthritis has been
described and emphasizes motivational interviewing,
individualized goal setting, tailored strategies for increas-
ing activity, and monitoring progress and an asses-
sment of barriers and drivers to physical activity [35].
In addition, for people with arthritis potential strategies
for increasing exercise participation include incorporating
pain management strategies and coping skills into
exercise interventions [36]. Mindfulness-basedcognitive
therapy (MBCT) and Mindfulness-BasedStress Reduc-
tion (MBSR) have been shown to be efficacious for
depression in RA [37], pain in osteoarthritis [38], and
also fatigue in multiple sclerosis [39]. Additionally,
behavioral therapy has already been shown to have
benefits for chronic pain and fatigue in arthritic condi-
tions [40], as well as increase adherence to exercise
programmes in obesity [41]. Thus, incorporating motiva-
tion interventions within exercise programmes could
allow people with AS to undertake increased self-manage-
ment, especially for those with higher disease activity
levels, where the observed effects on function were
more pronounced. Our study suggests that it is psycho-
logical interventions that result in improved intrinsic
motivation that may provide the most benefit for
patients—mindfulness-based interventions in particular
could be of value.
S. Brophy et al. 625CONCLUSIONS
Both exercise and motivation to exercise have a significant
effect on the functional ability of people with AS.
Motivation to exercise is also just as important as exercise
levels and has a direct effect on function as well as an
additional indirect effect through improving activity
levels. Exercise is an important factor in maintaining
function for people with AS and is particularly important
for those with higher disease activity levels.REFERENCES
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